Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05232253 · ClinicalTrials.gov registry record · NA
Cystoealstometer (Bladder Monitor Device)-Home Use
A NA study of Urinary Bladder, Neurogenic, sponsored by University of Iowa.
- Active
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT05232253: Active NA study of Urinary Bladder, Neurogenic, sponsored by University of Iowa.
NCT05232253 is a NA study of Urinary Bladder, Neurogenic that is active but no longer recruiting, run by University of Iowa. The registered enrollment target is 30 participants, below the 67-participant average among 7 other Urinary Bladder, Neurogenic trials with a reported enrollment target (55% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05232253, a NA study of Urinary Bladder, Neurogenic, is active but no longer recruiting, sponsored by University of Iowa.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators have developed a novel pressure monitoring device called a 'cystoelastometer' that connects to a drainage end ofastandard urinary catheters that are used by patients with a neurogenic bladder on daily clean intermittent catheterization. The device has already been demonstrated to be accurate in measuring bladder pressure compared to the gold standard urodynamics that are performed in the clinic or hospital. This study will assess the patients and care givers ability and experience using the cystoelastometer device in a home setting.
Primary Outcome
Utilization study of novel external cystoelastometer device - Home bladder pressure and volume monitor recorded in terms of cm H2O pressure and urine evacuation device with volume measurement in terms of milliliters.
Conditions Studied
Interventions
- DEVICE Cystoelastometer - Urodynamics Testing
Study Locations (1)
Iowa
- University of Iowa Hospital and Clinics - Iowa City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2021-01-18 |
| Est. Completion | 2027-02-01 |
| Phase | NA |
What the registry record for NCT05232253 still lists
NCT05232253 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 67-participant average among 7 other Urinary Bladder, Neurogenic trials with a reported enrollment target (55% lower).
The record links to 1 condition, with Urinary Bladder, Neurogenic appearing as the primary indexed condition, and to 1 intervention - of which Cystoelastometer - Urodynamics Testing is the first listed.
NCT05232253 reports a single indexed study location in Iowa.
Frequently Asked Questions
What is clinical trial NCT05232253 about?
NCT05232253 is a clinical study titled "Cystoealstometer (Bladder Monitor Device)-Home Use". The investigators have developed a novel pressure monitoring device called a 'cystoelastometer' that connects to a drainage end ofastandard urinary catheters that are used by patients with a neurogenic bladder on daily clean intermittent catheterization. The device has already been demonstrated to b...
What is the current status of trial NCT05232253?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2021-01-18. Estimated completion is 2027-02-01.
What conditions does trial NCT05232253 study?
This clinical trial studies the following conditions: Urinary Bladder, Neurogenic.
What interventions are being tested in trial NCT05232253?
The interventions under investigation include: Cystoelastometer - Urodynamics Testing (DEVICE).
Who is sponsoring clinical trial NCT05232253?
This trial is sponsored by University of Iowa, which has 228 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05232253 being conducted?
This trial has 1 study location across Iowa. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Urinary Bladder, Neurogenic
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Measurement of Bladder Pressure With a Novel External Device (Cystomanometer) - Home Use
RECRUITING · NA
-
Recovery of Bladder and Sexual Function After Human Spinal Cord Injury
RECRUITING · NA
-
Evaluation of a Bowel and Bladder Health Management Program for Individuals With Spinal Cord Injury (SCI)
COMPLETED · NA
-
Connected Catheter Clinical Feasibility Study( CFS)
COMPLETED · NA
-
NXT Post-Market Clinical Follow-up
RECRUITING
-
Feasibility of Triggered Sacral Neuromodulation for Neurogenic Bladder
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI